Nuvera’s PURE Engagement research, built on feedback from more than 2,300 physicians and support staff, ranks 2026 patient support leaders by company size and therapeutic area.
|Articles|March 20, 2023
PAP 2023: Corey Ford Discusses Questions from the State of the Industry Address at Access PAP 2023
Corey Ford dives into questions brought up during his 'state of the union' presentation.
Advertisement
In an interview with Pharma Commerce Editor, Nicholas Saraceno, Corey Ford, VP of reimbursement & policy insight, AmerisourceBergen, comments on questions asked during State of the Industry address at Access PAP 2023.
Advertisement
Related to this article
Accessia Health’s Tiara Green says Part D reforms eased drug costs, but premiums, deductibles and payer policies still limit patient access.
Jon Hamrick, partner at Curatio Advisors, discusses how product attributes, company size and stakeholder alignment shape pharma commercialization strategy.
At LogiPharma USA 2026, Mark Talens explains how end-to-end visibility lets pharma see its value chain across functions, and where supply chain monitoring is headed next.
Walgreens adds GLP-1 coverage navigation, Medicare Bridge support and pharmacist outreach to its virtual weight management service.
GEODIS' David Frouin explains why securing the lane outranks sustainability and why full corridor models are the cold chain trend to watch.
BMS’s Kevin Cook explains why digital capability is becoming a must-have for strategic CMO partners and why the next phase starts with the basics.
At LogiPharma USA 2026, Freehand's Nitin Jayakrishnan explains why AI and the people supply chain will shape pharma supply strategy.
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Big Three Distributors Lean on Specialty for Profit Growth
2
Pharma Pulse: CVS Health to Break in Two, Bayer Weighs MFN
3
2026 Brought Progress on Drug Prices. What Will It Take to Improve Patient Access in 2027?
4
The System-Level View That Sound Market Access Decisions Are Missing
5